Melanoma Clonal Heterogeneity Leads to Secondary Resistance after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes.
König D, Sandholzer MT, Uzun S, Zingg A, Ritschard R, Thut H, Glatz K, Kappos EA, Schaefer DJ, Kettelhack C, Passweg JR, Holbro A, Baur K, Medinger M, Buser A, Lardinois D, Jeker LT, Khanna N, Stenner F, Kasenda B, Homicsko K, Matter M, Rodrigues Mantuano N, Zippelius A, Läubli H.
König D, et al. Among authors: zingg a.
Cancer Immunol Res. 2024 Jul 2;12(7):814-821. doi: 10.1158/2326-6066.CIR-23-0757.
Cancer Immunol Res. 2024.
PMID: 38631025